Cargando…
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma
Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with erythroderma, 21 were diagnosed with eczema, 17 with psoriasis, 20 with drug-induced erythroderma, 13 w...
Autores principales: | LUHERNE, Camille, MENGUY, Sarah, FERTE, Thomas, BEYLOT-BARRY, Marie, SENESCHAL, Julien, MILPIED, Brigitte, VIAL, Jean-Philippe, GROS, Audrey, AMINTAS, Samuel, VERGIER, Béatrice, PHAM-LEDARD, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558750/ https://www.ncbi.nlm.nih.gov/pubmed/35758515 http://dx.doi.org/10.2340/actadv.v102.1062 |
Ejemplares similares
-
TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma
por: Gros, Audrey, et al.
Publicado: (2017) -
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
por: Poglio, Sandrine, et al.
Publicado: (2020) -
Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling
por: Gros, Audrey, et al.
Publicado: (2022) -
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System
por: Roccuzzo, Gabriele, et al.
Publicado: (2022) -
Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
por: Eldani, Céline, et al.
Publicado: (2023)